Claritev (CTEV) Competitors

$16.17 -0.25 (-1.52%)

As of 05/19/2026 03:58 PM Eastern

CTEV vs. FIVN, STGW, CLVT, GLOB, and BRAI

Should you buy Claritev stock or one of its competitors? MarketBeat compares Claritev with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Claritev include Five9 (FIVN), Stagwell (STGW), Clarivate (CLVT), Globant (GLOB), and Braiin (BRAI). These companies are all part of the "business services" industry.

How does Claritev compare to Five9?

Five9 (NASDAQ:FIVN) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

In the previous week, Claritev had 5 more articles in the media than Five9. MarketBeat recorded 15 mentions for Claritev and 10 mentions for Five9. Claritev's average media sentiment score of -0.14 beat Five9's score of -0.14 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Five9	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	1 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral

Five9 has a net margin of 4.87% compared to Claritev's net margin of -29.27%. Five9's return on equity of 12.66% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Five9	4.87%	12.66%	5.52%
Claritev	-29.27%	N/A	-4.36%

Five9 presently has a consensus price target of $26.53, suggesting a potential upside of 17.82%. Claritev has a consensus price target of $27.25, suggesting a potential upside of 68.52%. Given Claritev's higher probable upside, analysts plainly believe Claritev is more favorable than Five9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Five9	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
Claritev	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Five9 has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market. Comparatively, Claritev has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

96.6% of Five9 shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 1.2% of Five9 shares are held by insiders. Comparatively, 7.4% of Claritev shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Five9 has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Five9	$1.15B	1.50	$39.42M	$0.66	34.12
Claritev	$965.41M	0.29	-$284.28M	-$17.33	N/A

Summary

Five9 beats Claritev on 13 of the 17 factors compared between the two stocks.

How does Claritev compare to Stagwell?

Stagwell (NASDAQ:STGW) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Stagwell has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stagwell	$2.91B	0.54	$29.10M	$0.07	89.86
Claritev	$965.41M	0.29	-$284.28M	-$17.33	N/A

Stagwell has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Claritev has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

35.6% of Stagwell shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 11.2% of Stagwell shares are held by company insiders. Comparatively, 7.4% of Claritev shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Claritev had 8 more articles in the media than Stagwell. MarketBeat recorded 15 mentions for Claritev and 7 mentions for Stagwell. Stagwell's average media sentiment score of 0.57 beat Claritev's score of -0.14 indicating that Stagwell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stagwell	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	1 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral

Stagwell has a net margin of 0.64% compared to Claritev's net margin of -29.27%. Stagwell's return on equity of 24.12% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stagwell	0.64%	24.12%	4.31%
Claritev	-29.27%	N/A	-4.36%

Stagwell presently has a consensus price target of $7.65, suggesting a potential upside of 21.62%. Claritev has a consensus price target of $27.25, suggesting a potential upside of 68.52%. Given Claritev's stronger consensus rating and higher possible upside, analysts plainly believe Claritev is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stagwell	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29
Claritev	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Stagwell beats Claritev on 11 of the 15 factors compared between the two stocks.

How does Claritev compare to Clarivate?

Claritev (NYSE:CTEV) and Clarivate (NYSE:CLVT) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Clarivate has a net margin of -5.61% compared to Claritev's net margin of -29.27%. Clarivate's return on equity of 8.82% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-29.27%	N/A	-4.36%
Clarivate	-5.61%	8.82%	3.86%

Clarivate has higher revenue and earnings than Claritev. Clarivate is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.29	-$284.28M	-$17.33	N/A
Clarivate	$2.46B	0.64	-$201.10M	-$0.21	N/A

Claritev has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Clarivate has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

Claritev currently has a consensus target price of $27.25, indicating a potential upside of 68.52%. Clarivate has a consensus target price of $3.22, indicating a potential upside of 29.97%. Given Claritev's stronger consensus rating and higher possible upside, analysts plainly believe Claritev is more favorable than Clarivate.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Clarivate	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

In the previous week, Claritev had 9 more articles in the media than Clarivate. MarketBeat recorded 15 mentions for Claritev and 6 mentions for Clarivate. Clarivate's average media sentiment score of 0.22 beat Claritev's score of -0.14 indicating that Clarivate is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	1 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral
Clarivate	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.2% of Claritev shares are held by institutional investors. Comparatively, 85.7% of Clarivate shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 22.9% of Clarivate shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Clarivate beats Claritev on 10 of the 16 factors compared between the two stocks.

How does Claritev compare to Globant?

Claritev (NYSE:CTEV) and Globant (NYSE:GLOB) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, Globant had 30 more articles in the media than Claritev. MarketBeat recorded 45 mentions for Globant and 15 mentions for Claritev. Globant's average media sentiment score of 0.31 beat Claritev's score of -0.14 indicating that Globant is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	1 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral
Globant	9 Very Positive mention(s)	5 Positive mention(s)	22 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Globant has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.29	-$284.28M	-$17.33	N/A
Globant	$2.45B	0.72	$102.92M	$2.46	16.34

Claritev has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Globant has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Globant has a net margin of 4.46% compared to Claritev's net margin of -29.27%. Globant's return on equity of 9.87% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-29.27%	N/A	-4.36%
Globant	4.46%	9.87%	6.51%

Claritev presently has a consensus price target of $27.25, suggesting a potential upside of 68.52%. Globant has a consensus price target of $64.81, suggesting a potential upside of 61.23%. Given Claritev's stronger consensus rating and higher possible upside, analysts plainly believe Claritev is more favorable than Globant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Globant	1 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.39

87.2% of Claritev shares are held by institutional investors. Comparatively, 91.6% of Globant shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 2.7% of Globant shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Globant beats Claritev on 13 of the 16 factors compared between the two stocks.

How does Claritev compare to Braiin?

Claritev (NYSE:CTEV) and Braiin (NASDAQ:BRAI) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Claritev had 1 more articles in the media than Braiin. MarketBeat recorded 15 mentions for Claritev and 14 mentions for Braiin. Braiin's average media sentiment score of -0.10 beat Claritev's score of -0.14 indicating that Braiin is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	1 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral
Braiin	0 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral

Braiin has lower revenue, but higher earnings than Claritev.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.29	-$284.28M	-$17.33	N/A
Braiin	$73.41M	19.68	N/A	N/A	N/A

Claritev presently has a consensus price target of $27.25, suggesting a potential upside of 68.52%. Given Claritev's stronger consensus rating and higher possible upside, equities analysts plainly believe Claritev is more favorable than Braiin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Braiin	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

87.2% of Claritev shares are owned by institutional investors. 7.4% of Claritev shares are owned by company insiders. Comparatively, 47.9% of Braiin shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Braiin has a net margin of 0.00% compared to Claritev's net margin of -29.27%.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-29.27%	N/A	-4.36%
Braiin	N/A	N/A	N/A

Summary

Claritev beats Braiin on 6 of the 11 factors compared between the two stocks.

Get Claritev News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEV vs. The Competition

Export

Metric	Claritev	Business services Industry	Medical Sector	NYSE Exchange
Market Cap	$279.92M	$1.68B	$6.24B	$22.83B
Dividend Yield	N/A	4.42%	2.80%	4.11%
P/E Ratio	-0.93	94.23	20.78	29.48
Price / Sales	0.29	5.92	531.21	23.24
Price / Cash	1.06	6.50	43.09	24.68
Price / Book	-1.18	6.69	9.81	4.61
Net Income	-$284.28M	$7.28M	$3.55B	$1.07B
7 Day Performance	-41.20%	-4.68%	-2.11%	-1.37%
1 Month Performance	-27.91%	-1.61%	-4.14%	-2.44%
1 Year Performance	-41.16%	-6.10%	28.35%	21.16%

Claritev Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEV Claritev	3.55 of 5 stars	$16.17 -1.5%	$27.25 +68.5%	-40.9%	$279.92M	$965.41M	N/A	3,000	Trending News Gap Down
FIVN Five9	4.4068 of 5 stars	$21.64 +4.3%	$26.53 +22.6%	-17.3%	$1.59B	$1.15B	32.79	2,910	Options Volume
STGW Stagwell	4.389 of 5 stars	$6.05 -1.1%	$7.65 +26.4%	+21.2%	$1.52B	$2.96B	86.43	12,629
CLVT Clarivate	2.8714 of 5 stars	$2.43 +3.6%	$3.22 +32.6%	-42.4%	$1.50B	$2.46B	N/A	12,000
GLOB Globant	4.0328 of 5 stars	$38.98 +14.4%	$67.82 +74.0%	-61.8%	$1.49B	$2.45B	15.84	28,773	Trending News Earnings Report Analyst Forecast Buyback Announcement Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CTEV) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Claritev (CTEV) Competitors